ArticleClinical kidney journal2023

Trial design of the MOTheR HDx study: a multicenter, open-label, prospective, randomized study to explore the morbidity and mortality in patients dialyzed with the Theranova HDx in comparison with online hemodiafiltration.

Patricia de Sequera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.